Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Non-Current Assets (2019 - 2025)

Pliant Therapeutics (PLRX) has disclosed Non-Current Assets for 7 consecutive years, with $28.8 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 17.02% to $28.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $125.8 million through Dec 2025, down 9.01% year-over-year, with the annual reading at $28.8 million for FY2025, 17.02% down from the prior year.
  • Non-Current Assets for Q4 2025 was $28.8 million at Pliant Therapeutics, down from $31.0 million in the prior quarter.
  • The five-year high for Non-Current Assets was $36.2 million in Q2 2024, with the low at $4.7 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $18.3 million, with a median of $11.4 million recorded in 2022.
  • The sharpest move saw Non-Current Assets plummeted 45.35% in 2023, then skyrocketed 481.4% in 2024.
  • Over 5 years, Non-Current Assets stood at $11.8 million in 2021, then fell by 12.5% to $10.3 million in 2022, then crashed by 35.43% to $6.7 million in 2023, then surged by 421.42% to $34.7 million in 2024, then decreased by 17.02% to $28.8 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $28.8 million, $31.0 million, and $32.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.